The review of the 2001 NHMRC/ASBT Clinical Practice Guidelines for the use of Blood Components is being undertaken. The funding and project management is provided by the National Blood Authority (NBA) on behalf of all governments.
The NBA has facilitated the formulation of a Steering Committee, Expert Working Group, and Clinical/Consumer Reference Groups.
The review will result in the production of 6 modules as part of a comprehensive, evidence-based Patient Blood Management Guidelines (external site).
Additional implementation tools are provided to assist you in applying these guidelines in your individual programs:
Australian blood standards and accreditation
ACSQHC Standards (Blood and Blood Products)
Standards from the Australian Commission on Safety and Quality in Health Care (ACSQHC) (external PDF) are integral to the accreditation process. They determine how, and against what, an organisation's performance will be assessed.
Standards for Blood and Blood Products are included in the 10 National Safety and Quality Health Service Standards for Australia. The intention of the Standard is to ensure that patients who receive blood and blood products do so appropriately and safely.
The NSQHS Standards have been operational since 1 Jan 2013.
Since 1 July 2011, accreditation undertaken by the Australian Council on Healthcare Standards (ACHS) (external site) assesses hospitals against the new EQuIP5 standards and criteria. These now incorporate specific references to patient blood management.
Blood, Drugs and Technology team
Office of the Chief Medical Officer
2nd Floor, C Block
189 Royal Street
East Perth 6009
Phone: 9222 2072